Skip to main content
OpenTrials
Completed

NCT Number: NCT01417754

Changes in Breast 3D Ultrasound Measurements Using Toremifene

To investigate if there are detectable changes in volume and circulation in breasts of healthy volunteers using toremifene 20 mg in luteal phase of the menstruation cycle versus nonmedicated cycle.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Circulatory; Change

Age range

25 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 3

Primary location

Porin Lääkäritalo

Pori, 28100, Finland

About this study

20 women were participated to this trial.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age 25-45 healthy person
  • regular menstrual cycles
  • safe contraception(for example sterilization or condom)

Exclusion criteria

  • gynecological or other type of cancer
  • hormonal contraception
  • pregnancy

Treatment and study plan

Toremifene

Drug

20mg toremifene per day in tablet form starting from the cycle day 15 and continued to premenstrual period. Medication using about 10 days per volunteer

Other names: trade name Fareston

Primary outcomes

  1. circulation changes of the breast

    Time frame: cycle day 23 to 26

Sponsors and collaborators

Lead sponsor

Satakunta Central Hospital

Other

Collaborators

  • Tampere University
  • Tampere University Hospital

Registry information

Official study title

Volume and Circulation Changes of The Breast in 3D Ultrasound During Toremifene Versus Nonmedicated Menstrual Cycle

Important dates

Study start
2010
Primary completion
2010
Study completion
2011
First posted
Aug 16, 2011
Registry last updated
Aug 23, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.